Back to Products
Flunarizine
Fluniam is indicated-
• Prophylaxis of classic (with aura) or common (without aura) migraine
• Symptomatic treatment of vestibular vertigo.
• Peripheral Vascular Disease (PVD)
• Motion sickness
• Refractory epilepsy resistant to conventional antiepileptic therapy.
Migraine Prophylaxis:
Starting Dose: 10 mg at night in patients less than 65 years of age and 5 mg
daily in patients older than 65 years. If, during this treatment depressive,
extrapyramidal or other unacceptable symptoms occur, administration should
be discontinued. If, after 2 months of this initial treatment, no significant
improvement is observed, the patient should be considered a non-responder
and administration should be discontinued.
Maintenance Treatment: If a patient is responding satisfactorily and if a
maintenance treatment is needed, the dose should be decreased to 5 days
treatment at the same daily dose with two successive medicine free days
every week. Even if the prophylactic maintenance treatment is successful
and well tolerated, it should be interrupted after 6 months and it should be
re-initiated only if the patient relapses.
Peripheral Vascular disease: 10 mg twice daily, up to 30 mg per day if
required.
Vertigo & motion sickness:
10-20 mg daily for adults and 5 mg daily for children (> 40 kg).
Epileptic seizure: 15-20 mg daily in adults and 5 to 10 mg daily for children
as an add-on therapy.
Fluniam 5 Tablet (60’s): Each box contains 60 Tablets in (6 x 10’s) in
Alu-PVdC blister pack.
Fluniam 10 Tablet (60’s): Each box contains 60 Tablets in (6 x 10’s) in
Alu-PVdC blister pack.
